Silent myocardial ischaemia is a common phenomenon in patients with coronary heart disease. However, very little is known about the underlying mechanisms of silent ischaemia. One potential pathway that may contribute to this absence of pain is increased blood pressure. The main aim of the current study was to assess the associations among blood pressure, pain and ischaemia in patients undergoing a standard exercise stress test. We hypothesized that patients who experienced chest pain during exercise would have lower baseline and peak blood pressures compared to those who did not experience chest pain. A total of 1355 patients (418 women) who underwent a single-photon emission computed tomography treadmill exercise stress test and had not experienced a cardiac event in the past 2 weeks participated in the current study. Myocardial perfusion defects were assessed at rest and during the stress challenge. Systolic blood pressure (SBP), diastolic blood pressure, heart rate (HR) and rate pressure product (RPP) were assessed during rest and at peak exercise. There were no main effects of either pain or ischaemia on the baseline cardiovascular variables. Peak exercise data revealed main effects of pain on SBP, RPP and HR, and main effects of ischaemia on SBP and RPP, controlling for age, sex, baseline level, medication status and cardiac history. These findings suggest that acute rather than chronic increases in blood pressure may be one mechanism to explain the phenomena of silent myocardial ischaemia in cardiac patients, and may potentially provide a target for future treatment strategies.
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Introduction
Silent myocardial ischaemia is a common phenomenon in patients with coronary heart disease (CHD). Patients failing to feel pain during ischaemia may delay or prevent seeking medical attention, and are at increased risk of cardiac morbidity and mortality. It has been estimated that 80% of ischaemic episodes in patients with coronary artery disease are asymptomatic. 1, 2 Even very serious and severe episodes of ischaemia may be asymptomatic, with an estimated 10-15% of myocardial infarctions being silent. 3 Further, approximately 50% of cardiac patients who report angina pectoris have episodes of silent ischaemia, 2 and even 25-33% of patients who are considered to be adequately treated continue to have silent ischaemia. 4 However, very little is known about the underlying mechanisms of silent ischaemia. One potential pathway that may contribute to this absence of pain is increased blood pressure.
Previous studies have noted significant reductions in sensitivity to acute experimental pain stimuli in hypertensive patients compared to normotensive individuals. [5] [6] [7] Furthermore, there is evidence to suggest that the negative association between blood pressure and pain is not just a phenomenon observed in those with hypertension, but represents a continuous association that extends into the normotensive range, such that as blood pressure increases pain sensitivity decreases. [8] [9] [10] [11] [12] Although there is currently little direct evidence, there are several reasons to suspect that this blood pressure-pain association, known as blood pressure-related hypoalagesia, might be related to silent ischaemia. For example, elevated blood pressure is commonly observed in CHD patients and is one of the main risk factors for atherosclerosis. 13, 14 Reductions in pain sensitivity have been associated with both sustained and acute increases in blood pressure in experimental animals as well as humans. [5] [6] [7] [15] [16] [17] Blood pressure-related hypoalagesia has been demonstrated with naturalistic, clinical pain as well as in response to well-controlled experimental pain stimuli. [18] [19] [20] Finally, data from a previous study found an association between resting blood pressure, 21 exercise blood pressure 22 and silent ischaemia in cardiac patients undergoing treadmill exercise. However, this last study included only patients who had ischaemia, significant coronary disease and used only electrocardiographic changes to define ischaemic episodes, which has a relatively high rate of false positives. 23, 24 The current study assessed the associations among blood pressure, pain and ischaemia in men and women undergoing a standard exercise singlephoton emission computed tomography (SPECT) stress test. We hypothesized that patients who experienced chest pain during exercise would have lower baseline and peak blood pressures compared to those who did not experience chest pain, independent of ischaemia, medical history, medications and exercise performance. Additionally, there would be an interaction effect of ischaemia and pain such that those patients with silent ischaemia would have the highest baseline and exercise induced blood pressures.
Materials and methods
Our study cohort has been described previously. 23 Our initial study was designed to assess the role of psychiatric morbidity in the prediction of ischaemia during exercise stress testing. For the current analyses, a total of 1355 patients referred for SPECT exercise stress tests between September 1998 and September 2000 in the Nuclear Medicine Service of the Montreal Heart Institute were included. To be eligible, patients had to be undergoing exercise stress testing, be between the ages of 18 and 75 years and speak either English or French. Patients were excluded if they had experienced a cardiac event in the past 2 weeks (e.g., myocardial infarction (MI)) or if they had a more prominent medical condition than CHD (e.g., cancer, chronic obstructive pulmonary disease). The study was approved by the Human Ethics Committee of the Montreal Heart Institute and written informed consent was obtained from all participants.
Patients presenting to the Nuclear Medicine Service of the Montreal Heart Institute on the day of their exercise stress test were injected with a radioisotope (Tc-99m-SESTAMIBI), instrumented for electrocardiogram (ECG) recording, and underwent exercise (treadmill; Bruce protocol) testing followed by SPECT imaging according to standard procedure. [25] [26] [27] All stress test performance and cardiovascular measures were collected at the time of exercise testing. Patients were maintained on their usual medication but asked to withhold taking b-blockers on the day of the exercise and rest SPECT studies. Immediately following SPECT imaging, a full-time research assistant sought patient consent and collected medical history information. Exercise stress test results were obtained for all patients within 24 h of the test.
Heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP) and chest pain were evaluated before, during and after the stress test by experienced cardiac electrophysiology technicians trained in the administration and assessment of exercise treadmill tests. HR was measured using a standard 12-lead ECG configuration (Marquette Medical Systems Inc., Milwaukee, WI, USA), and blood pressure was measured using a manual sphygmomanometer (Welch Allyn Tycos-767 series, Skaneateles Falls, NY, USA). Mean predicted HR was calculated using standard age-adjusted methods. 26 Rate pressure product (RPP) was calculated as (SBP Â HR)/100. ECG Ischaemia was defined as ST depression 41.0 mm for at least three beats. Every minute during the test, patients were asked if they were experiencing any pain. If the patient indicated the presence of pain, they were asked to indicate where the pain was and, using a standard 6-20 Borg scale, how much pain they were experiencing. In the current study, only the data for chest pain were used and reported as either present (1) or absent (0). The final stress test report, which was used in the current study, included the details of the resting and peak exercise cardiovascular measures, whether patients experienced chest pain during the stress test, presence of ECG ischaemia, estimated total exercise mets (3.5 ml/kg/O 2 /min) and total exercise duration (seconds).
SPECT images were obtained using a triple-head, large field of view camera equipped with lowenergy, high-resolution, parallel-hole collimators. Sixty-four projections were acquired over 3601 variable elliptic orbit on a 64 Â 64 Â 16-byte matrix with a zoom of 1.44, using a 20% symmetric energy window centred on the 140 keV peak. Processing was performed using filtered back-projection with a Butterworth filter (cutoff 0.7, order 8) without attenuation correction. Short-axis slides, each one pixel thick (5.3 mm), were reconstructed and displayed as a two-dimensional polar map. Patients were considered to have ischaemia during the test if their SPECT assessments (Irix-3 model, Philips Inc., Cleveland, OH, USA) revealed reversible myocardial perfusion defects at peak exercise compared to rest. Owing to the nature of the study, the presence or absence of ischaemia was used (as this is what was reported in the patient report), rather than a measure of the degree of ischaemia. All ischaemia assessments were conducted by experienced nuclear cardiology physicians, with borderline cases being re-evaluated by at least two nuclear cardiology physicians who had to reach a consensus for patients to receive a positive diagnosis of ischaemia. As this is a retrospective study, all technicians and physicians were blinded to the goals of the study.
Two series of w 2 analyses were conducted to assess differences between (a) patients with and without pain and (b) patients with and without ischaemia on binary demographic, cardiac history and medication variables. A series of 2 (ischaemia) Â 2 (pain) general linear models were used to test for differences in continuous demographic variables between groups. The same general linear models were used to analyse differences in exercise cardiovascular measures, with the addition of age, sex, medication status (presence or absence of anti-ischaemic, antihypertensive medications and aspirin) and cardiac history (previous myocardial infarction (MI), previous percutaneous coronary intervention (PCI), previous coronary artery bypass grafet (CABG), diabetes, hyperlipidemia and hypertension) included as covariates. For analyses of peak data, the corresponding baseline measure of the cardiovascular variable and exercise duration were also added to the models. These variables were included as they all have shown a significant influence on either the presentation of pain or ischaemia in a CHD population. All statistical analyses were performed using SAS (version 8.2, Cary, NC, USA). All data are presented in a four-group design (no pain-no ischaemia (NP-NI), no pain-ischaemia (NP-I), pain-no ischaemia (P-NI) and pain-ischaemia (P-I)).
Results
The analyses revealed that patients who were ischaemic during the exercise test were more likely to be older (F ¼ Table 1 , there were significant main effects of ischaemia for each cardiovascular medication (with the exception of diuretics) and significant main effects of pain for each medication (with the exception of diabetic medications). In the analyses of the average number of cardiovascular medications taken, there were significant main effects for pain (F ¼ 53.76, Po0.0001) and ischaemia (F ¼ 90.66, Po0.0001) and a pain Â ischaemia interaction Table 1 Participants' demographic and medication variables as a function of group (NP-NI, NP-I, P-NI and P-I) Abbreviations: ACE, angiotensin-converting enzyme; CHD, coronary heart disease; MI, myocardial infarction; NP-I, no pain-ischaemia; NP-NI; no pain-no ischaemia; P-I, pain-ischaemia; P-NI, pain-no ischaemia. .0001) for the presence of ECG ischaemia, with post hoc analyses revealing that P-I patients were more likely to have ECG ischaemia than the other three groups. There was no difference between the NP-NI, NP-I and P-NI groups.
Analyses of baseline cardiovascular data revealed no main effects of pain (SBP -F ¼ 0.18, P ¼ 0.672; DBP -F ¼ 3.16, P ¼ 0.076; HR -F ¼ 0.29, P ¼ 0.591; RPP -F ¼ 0.48, P ¼ 0.490) or ischaemia (SBP -F ¼ 0.67, P ¼ 0.414; DBP -F ¼ 0.13, P ¼ 0.720; HR -F ¼ 3.50, P ¼ 0.062; RPP -F ¼ 3.13, P ¼ 0.077). There was, however, a pain Â ischaemia interaction for DBP (F ¼ 5.81, P ¼ 0.016) such that the NP-I and P-NI groups were significantly lower than the NP-NI group. There were no other significant interactions. All baseline analyses used age, sex, medication status and cardiac history as covariates. Peak exercise data (see Figure 1 , where F and P-values are reported) revealed independent main effects of pain and ischaemia on SBP, RPP and HR. There were no main effects for peak DBP and no significant pain Â ischaemia interactions for any of the measures. All peak exercise data analyses used age, sex, medication status, cardiac history, exercise duration and the appropriate baseline cardiovascular measure as covariates. Patients who experienced pain had lower peak exercise SBP, RPP and HR compared to those patients who did not have pain, independent of exercise duration, cardiac history, mediation status and baseline cardiovascular levels. Patients who had ischaemia also had lower SBP, RPP and HR compared to non-ischaemic participants, controlling for the above covariates. It should be noted that when patients who did not have ischaemia (n ¼ 590 for patients with ischaemia) were excluded from the analyses (with all pre-mentioned covariates included), there were no main effects of pain on resting levels and peak levels of DBP and HR. However, the main effects of pain on peak exercise SBP and RPP persisted.
Discussion
As hypothesized, the results of the current study reveal that patients who experience chest pain during an exercise tolerance test have significantly lower peak SBP in comparison to patients who did not experience chest pain. This result was significant even after controlling for age, sex, exercise duration, medication status, cardiac history and baseline level. Contrary to our hypothesis, we found no effects of pain on resting levels of SBP. These results are consistent with a previous study by Go et al., 22 which found that among patients with significant CHD and ECG ischaemia, SBP at the ischaemic threshold was higher in patients who experienced pain compared to those that did not experience pain, whereas there was no difference in resting blood pressure levels. It was surprising that we did not observe an interaction effect of ischaemia and pain, indicating that acute increases in blood pressure are related to decreases in pain irrespective of ischaemia status. However, patients who experience neither Abbreviations: DBP, diastolic blood pressure; ECG, electrocardiogram; HR, heart rate; METs, metabolic equivalents; MPHR, mean predicted heart rate; NP-I, no pain-ischaemia; NP-NI; no pain-no ischaemia; P-I, pain-ischaemia; P-NI, pain-no ischaemia; RPP, rate pressure product; SBP, systolic blood pressure. As RPP is a surrogate marker for myocardial oxygen consumption, 30 it is unsurprising to find that, at peak exercise, patients with ischaemia had lower levels of RPP compared to non-ischemic patients, which is in agreement with previous studies. 31 What is more interesting is the main effect of pain on RPP. Exercise-induced increases in RPP are caused by an alteration to the normal resting baroreceptive reflex mechanism by a rightward 'resetting' of the baroreflex response curves for HR and BP. 32, 33 These changes are related to a combination of altered central command and activation of the skeletal muscle afferents. 33 The fact that patients who experienced pain had lower RPPs compared to those who did not experience pain, suggests possible differential baroreflex response curves between the two groups.
Contrary to our hypotheses and a previous study, 34 patients who had pain were more likely to have been diagnosed with hypertension. However, there was no significant difference in resting SBP before the exercise test. As the diagnosis of hypertension was based on patient self-report with confirmation from chart review, where possible, and not from a physician's diagnosis, we felt that further examination of this finding was required. The fact that there was a difference in hypertension diagnoses but no difference in resting blood pressure levels lead us to consider the effects medication might have on the relationship. To test this, we ran two statistical models to see whether there was a significant effect of chest pain on hypertension diagnoses, and how this effect would change controlling for whether a patient was taking any hypertensive medication or not. The first model confirmed the w 2 analyses with significantly more pain patients having hypertension (52 vs 41%; F ¼ 9.69, P ¼ 0.002). However, when medication status was entered into the model, the main effect for pain disappeared, with corrected rates of hypertension equivalent in both the pain (44%) and no pain (43%) groups (F ¼ 0.13, P ¼ 0.718).
Although there is clear evidence from previous studies of an association between pain and blood pressure and models have been proposed, 35 the exact mechanism underlying this relationship has yet to be determined. The fact that peak blood pressure and not resting blood pressure was increased in patients with cardiac pain suggests that acute changes in blood pressure, rather than chronic elevation, maybe the key component in the hypertension-hypoalagesia relationship in patients with CHD. Further, given that exerciseinduced RPP was significantly different between those patients who did and did not experience pain suggests that acute baroreflex dysregulation is a possible mechanism in this population. In concordance with this, previous research has found links between baroreflex sensitivity and the hypertension-hypoalagesia phenomenon. [36] [37] [38] For example, cardiac cycle synchronized acute baroreceptor stimulation 37 and natural activation of baroreceptors 36 produced decreased pain perception in humans. However, it is also possible that other mechanisms, possibly in conjunction with baroreflex dysregulation, may play a role in the blood pressure-pain relationship. 17, 35 It has been suggested that both endogenous opioid responsivity and the stimulation of descending central pain modulation may be alternative mechanisms in Figure 1 Participants' mean (s.e.) peak exercise systolic blood pressure (SBP; a), diastolic blood pressure (DBP; b), heart rate (HR; c) and rate pressure product (RPP; d) as a function of group (no pain-no ischaemia (NP-NI), no pain-ischaemia (NP-I), pain-no ischaemia (P-NI) and pain-ischaemia (P-I)):
explaining the reduction of pain sensitivity with increasing blood pressure. 35 In general, it is thought that the connections between pain and cardiovascular regulatory mechanisms are part of a system to coordinate behavioural and physiological responses to potentially life-threatening emergency situations, but which also influences day-to-day activity. 5, 39 As pain is a natural adaptive process which aids survival, 40 it is no surprise that patients who have maladaptive pain responses, that is, those with silent ischaemia, have worse morbidity and mortality than patients who experience pain during ischaemic episodes. 28, 29 It may be that owing to their inability to correctly interpret chest pain, patients with silent ischaemia fail to undertake protective behaviours, such as, taking medications and seeking appropriate medical help. One important area in this field which has yet to be defined is if it is possible to alter the hypertension-hypoalagesia relationship. Although one study failed to show a reduction in pain sensitivity to electrical tooth pulp stimulation with a reduction in blood pressure in a small number of hypertensives taking diuretics or b-blockers, 41 it is conceivable that pharmacological or behavioural interventions may be able to alter the pain-blood pressure relationship. Such interventions may prove to be beneficial to patients with silent ischaemia.
There are a few limitations to the study that need to be highlighted. Most notably, this is a retrospective study and as such the measure of pain is adequate but basic. Pain is a multifactorial phenomena with affective/motivational components (related to the limbic effects of pain) as well as sensory dimensions. 42 Several studies of blood pressurerelated hypoalagesia suggest that blood pressure dampens primarily the affective dimension of pain.
12,43 Unfortunately, we did not assess any affective or sensory components of pain and, therefore, cannot tease out their relative relationships to blood pressure in the current study. Future studies should include a wider range of pain measures in order to better evaluate the experience of pain in patients undergoing stress testing. Although the current study suggests that the baroreflex may be the mechanism linking pain and blood pressure, our study design prevents us from determining whether this is due to a peripheral or central effects. Although previous research, in non-exercise settings, has suggested a central effect of baroreflex stimulation, [36] [37] [38] it is also possible that there may be a direct peripheral mechanism, a pathway that cannot be discounted by the current study. This is further complicated by the inherent problems of measuring spontaneous baroreflex sensitivity during exercise (i.e., the inability to measure the full function curve). 33 Finally, as mentioned previously, other mechanisms, which go beyond the scope of this study, may also be involved, and should be explored in future research.
In conclusion, the present study found that, independent of age, sex, exercise duration, ischaemia, medication status and cardiac history, the experience of chest pain during exercise testing was associated with an increase in peak exercise SBP and RPP. These findings suggest that acute, rather than chronic, increases in blood pressure may be one mechanism to explain the phenomenon of silent myocardial ischaemia. These findings may have implications for clinical management of silent ischaemia, as they suggest potential targets for intervention.
